EuroAtaxia 2009 (Valladolid, Spain, organised by Fedaes on September 25, 2009) - Audio selection

Dr. Massimo Pandolfo. (Hôpital Erasme-Université Libre de Bruxelles, Belgium) “Current state of histone deacetylase inhibitors investigation’’.

Part 1:

Part 2:

Part 3:

Dr. Daniele Marmolino. Laboratoire de Neurologie Expérimentale, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. “PPARgamma agonists: potential treatment for Friedreich's Ataxia”.

Part 1:

Part 2:

Dr. Ignacio Torres Alemán: Laboratory of Neuroendocrinology. (Institute Cajal. CSIC. Madrid) "IGF-I and Friedreich Ataxia”.

Part 1:

Part 2:

Dr. Javier Diaz Nido. Department of Molecular Biology. Centre of Molecular Biology "Severo Ochoa" (CSIC-UAM). University Autonoma of Madrid. ”Knock-down of frataxin gene expression in human neuron-like cells as a cell model for Friedreich´s ataxia”.

Part 1:

Part 2:

Dr. Filip Lim. Faculty of sciences. Department of Molecular Biology Severo Ochoa. University Autónoma of Madrid. "Neuronal cell models derived from olfactory mucosa biopsies of Friedreich's ataxia patients"

Part 1:

Part 2:

Dr. Richard Wade-Martins. University of Oxford Department of Physiology, Anatomy and Genetics.“Expression analysis of the expanded FRDA locus using high capacity genomic DNA vectors”.

Part 1:

Part 2:

Dr. Mark Pook (Brunel University, London, UK) "Analysis of GAA instability and epigenetic changes in Friedreich ataxia using a GAA repeat-containing FXN transgenic mouse model".

Part 1:

Part 2:

Dr. Salvatore Adinolfi (Annalisa Pastore’s team) "Frataxin is the gatekeeper of Fe-S cluster formation"

Part 1:

Part 2:

Dr. Jonathan Jones. Institute of Neurosciences. University Miguel Hernández. San Joan Campus. Alicante. "Cellular therapy as a neuroprotective therapeutic approach in ataxia: experimental studies in animal and cellular models"

Part 1:

Part 2:

Dr. Francisco Javier Arpa. Department of Neurology. Hospital La Paz.- Madrid. “Clinical trials in adults with Deferriprone, idebenone, Riboflavin, IGF-1”

Part 1:

Part 2:

Part 3:

Dr.Mercedes Pineda. Neuropediatrics. Sant Joan de Deu Hospital. Barcelona. “Treatment with idebenone and deferiprone in Friedreich ataxia patients”

Part 1:

Part 2:

Dr. Giuseppe De Michele. Dipartimento di Scienze Neurologiche. Università Federico II. Náples. Italy. “Erythropoietin and Friedreich ataxia: preliminary results of a phase II open-label clinical trial”

Part 1:

Part 2:

Dr. Pierre Rustin Hopital Robert Debre, Paris. France. "Pioglitazone in FRDA: Why and How?

Part 1:

Part 2:

Part 3: